MedTrace Logo

Patient-Reported Outcome Measures in Cardiac Rehabilitation: Impact on Health Care

NCT06032013 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2024-07-31

No results posted yet for this study

Summary

Cardiac Rehabilitation (CR) programs are a multidisciplinary process aimed at patient recovery after an acute cardiovascular event or with chronic heart disease, reducing mortality and morbidity, optimising functional capacity and improving quality of life. The aim is to maintain or recover the patient's clinical, physical and psychosocial condition, slowing down or halting the progression of the underlying disease process. It is based on the practice of personalized physical exercise and the adaptation of behaviours towards a healthier lifestyle, ensuring the reduction and control of risk factors. It is considered a cost-effective intervention that is explicitly and formally recommended by the most diverse and important scientific societies. Through the partnership and collaboration between the various health institutions and the academy, the CR program will take place on an outpatient basis, in a supervised manner, starting after risk stratification with a stress test and respective clinical assessment by a cardiologist. The coordinator of the CR program will be a cardiologist, and the entire multidisciplinary team will be responsible for effectiveness and safety, as well as patient assessment and progress.

Conditions

  • Quality of Life
  • Cardiac Rehabilitation
  • Patient-Reported Outcome Measures
  • Rehabilitation Exercise

Interventions

OTHER

Cardiac rehabilitation program (PROMs)

The program is multidisciplinary with the following components: * Medical assessment * Physical training and counselling on physical activity * Identification and control of risk factors * Nutritional assessment and counselling * Psychological assessment and intervention * Education and information

Sponsors & Collaborators

  • José Manuel Afonso Moreira

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2024-03-01
Completion
2024-04-01

Countries

  • Portugal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06032013 on ClinicalTrials.gov